nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.03.2012 | Letter to the Editor

Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

verfasst von: Sauli Savolainen, Mark Konijnenberg, Manuel Bardiès, Michael Lassmann, Lidia Strigari, Carlo Chiesa, Arturo Chiti, Vappu Reijonin, Glenn Flux

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Kunikowska J, Królicki L, Hubalewska-Dydejczyk A, Mikołajczak R, Sowa-Staszczak A, Pawlak D. Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/(177)Lu-DOTATATE: which is a better therapy option? Eur J Nucl Med Mol Imaging 2011;38:1788–97. doi:10.1007/s00259-011-1833-x.PubMedCrossRef

Brans B, Mottaghy FM, Kessels A. (90)Y/(177)Lu-DOTATATE therapy: survival of the fittest? Eur J Nucl Med Mol Imaging 2011;38:1785–7. doi:10.1007/s00259-011-1878-x.PubMedCrossRef

Hindorf C, Chittenden S, Causer L, Lewington VJ, Mäcke HR, Flux GD. Dosimetry for (90)Y-DOTATOC therapies in patients with neuroendocrine tumors. Cancer Biother Radiopharm 2007;22(1):130–5.PubMedCrossRef

Cremonesi M, Botta F, Di Dia A, Ferrari M, Bodei L, De Cicco C, et al. Dosimetry for treatment with radiolabelled somatostatin analogues. A review. Q J Nucl Med Mol Imaging 2010;54(1):37–51.PubMed

Barone R, Borson-Chazot F, Valkema R, Walrand S, Chauvin F, Gogou L, et al. Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship. J Nucl Med 2005;46:99S–106S.PubMed

de Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP. Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs. J Nucl Med 2005;46(Suppl 1):13S–7S.PubMed

Titel: Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail
verfasst von: Sauli Savolainen
Mark Konijnenberg
Manuel Bardiès
Michael Lassmann
Lidia Strigari
Carlo Chiesa
Arturo Chiti
Vappu Reijonin
Glenn Flux
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-011-2036-1

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

Excerpt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials

Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer

Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial

Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy

Erratum to: Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

Extremity doses of nuclear medicine personnel: a concern